Tonix Pharmaceuticals Holding (TNXP) EPS (Weighted Average and Diluted) (2023 - 2025)
Historic EPS (Weighted Average and Diluted) for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to -$3.59.
- Tonix Pharmaceuticals Holding's EPS (Weighted Average and Diluted) rose 8417.11% to -$3.59 in Q3 2025 from the same period last year, while for Sep 2025 it was $279.28, marking a year-over-year increase of 10163.74%. This contributed to the annual value of -$176.6 for FY2024, which is 9880.03% up from last year.
- Per Tonix Pharmaceuticals Holding's latest filing, its EPS (Weighted Average and Diluted) stood at -$3.59 for Q3 2025, which was up 8417.11% from -$3.86 recorded in Q2 2025.
- Over the past 5 years, Tonix Pharmaceuticals Holding's EPS (Weighted Average and Diluted) peaked at -$2.84 during Q1 2025, and registered a low of -$14576.8 during Q4 2023.
- Over the past 3 years, Tonix Pharmaceuticals Holding's median EPS (Weighted Average and Diluted) value was -$30.02 (recorded in 2024), while the average stood at -$1903.9.
- As far as peak fluctuations go, Tonix Pharmaceuticals Holding's EPS (Weighted Average and Diluted) surged by 4128.92% in 2024, and later soared by 9979.9% in 2025.
- Tonix Pharmaceuticals Holding's EPS (Weighted Average and Diluted) (Quarter) stood at -$14576.8 in 2023, then skyrocketed by 99.79% to -$30.02 in 2024, then soared by 88.04% to -$3.59 in 2025.
- Its last three reported values are -$3.59 in Q3 2025, -$3.86 for Q2 2025, and -$2.84 during Q1 2025.